Log In
BCIQ
Print this Print this
 

PanAd3-MVA Universal flu vaccine

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionHeterologous prime boost regimen with vectors encoding a string of engineered Influenza A proteins, HA, NP and M1 bearing both B and T cell epitopes
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationInfluenza virus
Indication DetailsPrevent influenza virus
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today